San Francisco, Dec 03 Global radiation
dose monitoring market is anticipated to reach a value of USD 3.9
billion by 2025, according to a new report by Grand View Research, Inc. The
advantage of automated dose monitoring systems to track individual and
cumulative radiation dose exposure in patients is driving significant demand
for the product.
Dose
monitoring is achieved by the use of software and designated products such as
dosimeters. Dose management software analyzes, identifies, and optimizes
radiation dose performance with precise data. This data aids the physicians to
provide quality care to the patients. Furthermore, easy integration of software
into existing medical architecture of hospitals will boost the value of
existing medical systems and ensure safety of using them.
Area
of application commonly employing the use of medical imaging is radiography,
angiography, mammography, fluoroscopy & interventional imaging and nuclear
medicine. Several medical imaging technology manufacturers are constantly
involving in the incorporation of the radiation dose monitoring tools in these
imaging platforms. X-ray and computed tomography technique are known to emit a
large amount of radiation as compared to other imaging platforms. The overall
market exhibits promising growth prospects pertaining to high prevalence of
chronic diseases, effective and reliable treatment methods focusing on care,
and increasing patient awareness.
Browse full research report on Radiation Dose Monitoring Market:
www.grandviewresearch.com/industry-analysis/radiation-dose-monitoring-market
Further key findings from the study suggest:
- North America
reported highest revenue growth in this market in 2015. A shift to the
value based care delivery model has resulted in healthcare providers to
divert their attention to deliver healthcare services concentrating on the
well-being of a patient
- Asia Pacific
region provides lucrative market opportunities for radiation dose
monitoring. Significant factors such as rapid urbanization, upgrade in
healthcare infrastructure and delivery will further support the market
growth in emerging economies like India and China
- The market
for radiation dose monitoring software is expected to generate strong
revenue growth in the fiscal year 2015. The software market enables easy
integration to existing architecture in healthcare facilities, and will
sync into the integrated care delivery benefitting the specialists to
provide better and monitored care
- The major
market players recognized in this market are GE Healthcare, Sectra,
Medicvision, Philips Healthcare, Toshiba MSC, Bayer AG, Landauer, Inc. and
Thermo Fisher Scientific, Inc.
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the radiation dose monitoring market by component,
application and product:
Component
Outlook (Revenue, USD Million; 2014 - 2025)
- Software
- Service
Application
Outlook (Revenue, USD Million; 2014 - 2025)
- Radiography
- Angiography
- Mammography
- Fluoroscopy
& Interventional Imaging
- Others
Product
Outlook (Revenue, USD Million; 2014 - 2025)
- Dosimeters
- Area Process
Monitors
- Others
Regional
Outlook (Revenue, USD Million; 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
- Saudi Arabia
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-radiation-dose-monitoring-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and fact-based
research across a range of industries, from technology to chemicals, materials
and healthcare.
For more information:
www.grandviewresearch.com
No comments:
Post a Comment